Our synthesized compounds were tested as anti-cancer candidates targeting VEGFR-2 inhibitors with the analysis of their apoptotic anti-proliferative activities, in the hope that this synergistic hybridization may lead to a more selective, safe, and efficient drug. This evidence concerns the gene KDR and cancer.